Biomerica BMRA
NASDAQ BMRA
$1.63 +0.04 (+2.83%)
As of: Aug 21, 2026 · 2:24 PM EDT

Biomerica (BMRA) Total Debt (2011 - 2012)

Biomerica (BMRA) posted Total Debt of $43000.0 for Q2 2012, up 266.21% sequentially from $11742.0 in Q4 2011, and up 21.5% YoY from $35390.0 in Q2 2011.

Biomerica (BMRA) Total Debt (2011 - 2012) Analysis & Trends

Biomerica has reported Total Debt for 2 years, with the latest figure at $43000.0 in Q2 2012.

  • Quarterly Total Debt rose 21.5% year-over-year to $43000.0 in Q2 2012, while the trailing twelve-month figure through May 2012 was $43000.0 (up 21.5% YoY) and the FY2012 annual result came in at $43000.0, up 21.5% from the prior year.
  • Total Debt climbed to $43000.0 in Q2 2012 per BMRA's latest filing, from $11742.0 in the prior quarter.
  • Over five years, Total Debt peaked at $43000.0 in Q2 2012 and troughed at $11742.0 in Q4 2011.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Abbott Laboratories 202.33 Bn 196.73 Bn 7.27 Bn 32.61 Bn
2 Stryker 126.42 Bn 122.94 Bn 4.50 Bn 14.94 Bn
3 Medtronic 119.31 Bn 110.09 Bn 6.41 Bn 27.96 Bn
4 Boston Scientific 74.10 Bn 73.56 Bn 3.85 Bn 12.62 Bn
5 Edwards Lifesciences 51.66 Bn 47.40 Bn 1.35 Bn 598.70 Mn
6 Dexcom 35.04 Bn 33.09 Bn 830.00 Mn -
7 GE HealthCare Technologies 33.75 Bn 31.65 Bn 2.18 Bn 10.10 Bn
8 Koninklijke Philips 26.20 Bn 22.88 Bn 4.55 Bn 8.68 Bn
9 Steris 23.16 Bn 22.68 Bn 684.20 Mn 1.89 Bn
10 Biomerica 4.91 Mn 3.57 Mn -44,000.00 -

Historic Data

Download Data
DateValue
May 31, 2012 43,000.00
Nov 30, 2011 11,742.00
Aug 31, 2011 23,664.00
May 31, 2011 35,390.00